Literature DB >> 16866196

Arthrogenic lameness of the fetlock: synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain.

J C de Grauw1, C H A van de Lest, R van Weeren, H Brommer, P A J Brama.   

Abstract

REASONS FOR PERFORMING THE STUDY: Joint pain is one of the most common causes of lameness in the horse but its pathogenesis is poorly understood.
OBJECTIVES: To investigate which synovial fluid markers may be related to the presence of clinically detectable joint pain in the horse.
METHODS: Concentrations of structural (CPII, C2C, GAG) and inflammatory markers (PGE2, LTB4, CysLTs, bradykinin and substance P) were measured in fetlock joint fluid from 22 horses in which lameness was localised to the fetlock region by perineural anaesthesia. Levels of these markers were then compared in horses that responded (n = 15) to those that did not (n = 7) to subsequent intra-articular anaesthesia (IAA).
RESULTS: Of all markers analysed, only substance P levels were significantly higher (P = 0.0358) in synovial fluid of horses that showed a positive response to IAA compared to those with a negative response to IAA. Notably, while PGE2 levels were found to be elevated in all 22 lame horses compared to sound controls (P = 0.0025), they were not related to the response to IAA.
CONCLUSIONS: While levels of PGE2 are elevated in synovial fluid of lame horses that respond to perineural anaesthesia, only substance P is related to joint pain as detected by the response to intra-articular anaesthesia. POTENTIAL RELEVANCE: Substance P is associated with clinically detectable joint pain in the horse. Elevated levels of PGE2 in fetlock-lame horses, regardless of their response to IAA, indicate that either this mediator does not reflect intra-articular pain or that IAA might have limitations in differentiating between intra- and peri-articular sources of pain. Either way, a negative response to IAA may not exclude intra-articular pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16866196     DOI: 10.2746/042516406777749236

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  6 in total

1.  Effects of aquatic conditioning on cartilage and bone metabolism in young horses.

Authors:  Brittany L Silvers; Jessica L Leatherwood; Carolyn E Arnold; Brian D Nielsen; Chelsie J Huseman; Brandon J Dominguez; Kati G Glass; Rafael E Martinez; Mattea L Much; Amanda N Bradbery
Journal:  J Anim Sci       Date:  2020-08-01       Impact factor: 3.159

2.  Evaluation of conjugated linoleic acid supplementation on markers of joint inflammation and cartilage metabolism in young horses challenged with lipopolysaccharide.

Authors:  Amanda N Bradbery; Josie A Coverdale; Kristine L Vernon; Jessica L Leatherwood; Carolyn E Arnold; Robin A Dabareiner; Meredith K Kahn; Allison A Millican; Thomas H Welsh
Journal:  J Anim Sci       Date:  2018-03-06       Impact factor: 3.159

3.  A time-course evaluation of inflammatory and oxidative markers following high-intensity exercise in horses: a pilot study.

Authors:  Jennifer L MacNicol; Michael I Lindinger; Wendy Pearson
Journal:  J Appl Physiol (1985)       Date:  2017-10-26

4.  The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint.

Authors:  Helka M Heikkilä; Anna K Hielm-Björkman; John F Innes; Outi M Laitinen-Vapaavuori
Journal:  BMC Vet Res       Date:  2017-03-21       Impact factor: 2.741

5.  Clinical Effects of the Extract of the Seeds of the Indian Celery-Apium Graveolens-In Horses Affected by Chronic Osteoarthritis.

Authors:  Beatrice Battaglia; Mario Angelone; Elena Vera; Giuseppina Basini; Simona Bussolati; Massimiliano Paci; Maurizio Del Bue; Raffaella Aldigeri; Stefano Grolli; Fausto Quintavalla; Roberto Ramoni
Journal:  Animals (Basel)       Date:  2019-08-20       Impact factor: 2.752

6.  Changes in biomarkers in equine synovial fluid two weeks after intra-articular hyaluronan treatment: a randomised double-blind clinical trial.

Authors:  Tytti M Niemelä; Riitta-Mari Tulamo; Kaisa Aaltonen; Satu M Sankari; Anna K Hielm-Björkman
Journal:  BMC Vet Res       Date:  2018-06-15       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.